HomeABOS • NASDAQ
add
Acumen Pharmaceuticals Inc
Previous close
$2.36
Day range
$2.38 - $2.63
Year range
$0.86 - $3.60
Market cap
184.14M USD
Avg Volume
721.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.67M | -7.06% |
Net income | -25.14M | 32.34% |
Net profit margin | — | — |
Earnings per share | -0.41 | 33.87% |
EBITDA | -25.19M | 36.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 116.86M | -31.88% |
Total assets | 122.83M | -48.60% |
Total liabilities | 52.40M | -8.35% |
Total equity | 70.43M | — |
Shares outstanding | 72.21M | — |
Price to book | 2.03 | — |
Return on assets | -47.54% | — |
Return on capital | -55.81% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -25.14M | 32.34% |
Cash from operations | -19.10M | 29.83% |
Cash from investing | 26.25M | -11.51% |
Cash from financing | 2.00K | 122.22% |
Net change in cash | 7.16M | 193.40% |
Free cash flow | -10.93M | 26.07% |
About
Founded
Jan 1, 1996
Headquarters
Website
Employees
60
